adjuvant

Showing: 1 - 1 of 1 Articles

DCGI approved AstraZeneca’s Lynparza as a monotherapy for adjuvant treatment of patients with high-risk early breast cancer

AstraZeneca India, a leading science-led biopharmaceutical company, today announced that it has received a Drugs …